Ian S Arthur
Overview
Explore the profile of Ian S Arthur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pieper A, Zangl L, Speigelman D, Feils A, Hoefges A, Jagodinsky J, et al.
Front Immunol
. 2021 Dec;
12:763888.
PMID: 34868010
Introduction: Combining CpG oligodeoxynucleotides with anti-OX40 agonist antibody (CpG+OX40) is able to generate an effective vaccine in some tumor models, including the A20 lymphoma model. Immunologically "cold" tumors, which are...
2.
Jagodinsky J, Jin W, Bates A, Hernandez R, Grudzinski J, Marsh I, et al.
Theranostics
. 2021 May;
11(13):6120-6137.
PMID: 33995649
Clinical interest in combining targeted radionuclide therapies (TRT) with immunotherapies is growing. External beam radiation therapy (EBRT) activates a type 1 interferon (IFN1) response mediated via stimulator of interferon genes...
3.
Clark P, Sriramaneni R, Bates A, Jin W, Jagodinsky J, Hernandez R, et al.
Radiat Res
. 2021 Apr;
195(6):522-540.
PMID: 33826741
Brain metastases develop in over 60% of advanced melanoma patients and negatively impact quality of life and prognosis. In a murine melanoma model, we previously showed that an in situ...
4.
Clark P, Sriramaneni R, Jin W, Jagodinsky J, Bates A, Jaquish A, et al.
J Immunother Cancer
. 2020 Jul;
8(2).
PMID: 32690669
Background: Immune checkpoint inhibition (ICI) alone is not efficacious for a large number of patients with melanoma brain metastases. We previously established an in situ vaccination (ISV) regimen combining radiation...